A NEW blood test could detect Alzheimer’s disease in its early stages, years before symptoms begin to show. Tests that ...

IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced data that reinforces the therapeutic potential of IGC-AD1 as a disease-modifying treatment for Alzheimer's disease. The data highlights ...

Two new papers by a team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also, critically, to predict the conversion ...

A new review shows that this process of thinking is not exclusive to humans. Artificial intelligence, too, is capable of self-correction and arriving at new conclusions through 'learning by thinking.' ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...